Rosuvastatin calcium and Red cell distribution width increased - a phase IV clinical study of FDA data

Summary:

Red cell distribution width increased is reported as a side effect among people who take Rosuvastatin calcium (rosuvastatin calcium), especially for people who are female, 60+ old, also take Allopurinol, and have Gastroesophageal reflux disease.

The phase IV clinical study analyzes which people have Red cell distribution width increased when taking Rosuvastatin calcium. It is created by eHealthMe based on reports of 24,757 people who have side effects when taking Rosuvastatin calcium from the FDA, and is updated regularly.

What is Rosuvastatin calcium?

Rosuvastatin calcium has active ingredients of rosuvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 25,356 Rosuvastatin calcium users. Check the latest studies of Rosuvastatin calcium.

What is Red cell distribution width increased?

Red cell distribution width increased is found to be associated with 604 drugs and 656 conditions by eHealthMe. Check the latest studies of Red cell distribution width increased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 31, 2026

24,757 people reported to have side effects when taking Rosuvastatin calcium.
Among them, 58 people (0.23%) have Red cell distribution width increased.

Could Rosuvastatin calcium cause Red cell distribution width increased?

Among these 58 people:

What is the gender of people who have Red cell distribution width increased when taking Rosuvastatin calcium? *

  • female: 63.27 %
  • male: 36.73 %

What is the age of people who have Red cell distribution width increased when taking Rosuvastatin calcium? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 6.25 %
  • 40-49: 0.0 %
  • 50-59: 35.42 %
  • 60+: 58.33 %

What are other drugs people take besides Rosuvastatin calcium? *

  1. Allopurinol: 20 people, 34.48%
  2. Prednisone: 19 people, 32.76%
  3. Folic Acid: 19 people, 32.76%
  4. Vitamin D3: 17 people, 29.31%
  5. Rabeprazole Sodium: 17 people, 29.31%
  6. Sulfasalazine: 16 people, 27.59%
  7. Acetazolamide: 16 people, 27.59%
  8. Ezetimibe: 16 people, 27.59%
  9. Arava: 16 people, 27.59%
  10. Methotrexate: 14 people, 24.14%

What are other side effects people have besides Red cell distribution width increased? *

  1. Haemoglobin Decreased: 41 people, 70.69%
  2. Haematocrit Decreased: 38 people, 65.52%
  3. Thrombocytopenia (decrease of platelets in blood): 24 people, 41.38%
  4. Mean Cell Haemoglobin Concentration Decreased (less concentration of haemoglobin in a given volume of packed red blood cells): 24 people, 41.38%
  5. Lymphocyte Count Decreased: 24 people, 41.38%
  6. Red Blood Cell Count Decreased: 22 people, 37.93%
  7. Aortic Arteriosclerosis (hardening of the aortic arteries): 21 people, 36.21%
  8. Eosinophil Count Increased: 20 people, 34.48%
  9. Joint Swelling: 19 people, 32.76%
  10. Mycobacterium Avium Complex Infection: 19 people, 32.76%

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 9 people, 15.52%
  2. Stress And Anxiety: 7 people, 12.07%
  3. Pneumonia: 6 people, 10.34%
  4. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 8.62%
  5. Ovarian Cancer (cancer of ovary): 4 people, 6.90%
  6. Thrombotic Thrombocytopenic Purpura (a rare blood disorder characterized by clotting in small blood vessels of the body): 4 people, 6.90%
  7. Hypersensitivity: 4 people, 6.90%
  8. High Blood Pressure: 4 people, 6.90%
  9. Restless Leg Syndrome (a powerful urge to move your legs): 4 people, 6.90%
  10. Depression: 3 people, 5.17%

* Approximation only. Some reports may have incomplete information.

Do you take Rosuvastatin calcium and have Red cell distribution width increased?

- Check whether Red cell distribution width increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rosuvastatin calcium:

Red cell distribution width increased treatments and more:

How severe was Red cell distribution width increased and when was it recovered:

Expand to all the drugs that have ingredients of rosuvastatin calcium:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Rosuvastatin calcium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Red cell distribution width increased:

Browse all the conditions that are associated with Red cell distribution width increased:


How the study uses the data?

The study uses data from the FDA. It is based on rosuvastatin calcium (the active ingredients of Rosuvastatin calcium) and Rosuvastatin calcium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: